BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1743265)

  • 1. In utero and milk-mediated effect of aldose reductase inhibitor on galactose cataracts.
    Unakar NJ; Tsui JY; Johnson M; Dang L
    Exp Eye Res; 1991 Nov; 53(5):665-76. PubMed ID: 1743265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitors and galactose toxicity in neonatal and maternal rat lenses.
    Unakar NJ; Tsui J; Anthony P; Johnson M
    J Ocul Pharmacol; 1993; 9(4):341-53. PubMed ID: 8106840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ; Tsui JY; Johnson MJ
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
    Unakar NJ; Harries W; Tsui J
    Exp Eye Res; 1985 Jan; 40(1):117-26. PubMed ID: 3920063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prefeeding of aldose reductase inhibitor inhibits galactose cataract].
    Tsuji T; Okamoto S; Ikebe H; Terubayashi H; Akagi Y; Tanimoto T
    Nippon Ganka Gakkai Zasshi; 1993 Apr; 97(4):455-9. PubMed ID: 8317365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats.
    Unakar NJ; Tsui JY; Johnson MJ
    J Ocul Pharmacol; 1992; 8(3):199-212. PubMed ID: 1453083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis by calpain is an underlying mechanism for formation of sugar cataract in rat lens.
    Azuma M; Inoue E; Oka T; Shearer TR
    Curr Eye Res; 1995 Jan; 14(1):27-34. PubMed ID: 7720403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of sugar cataract in the dog.
    Sato S; Takahashi Y; Wyman M; Kador PF
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.